Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

iCoreConnect expands into Tennessee with TDA endorsement

EditorNatashya Angelica
Published 04/23/2024, 02:17 PM

OCOEE, FL - iCoreConnect Inc. (NASDAQ: ICCT), a cloud-based software and technology firm, has secured an endorsement from the Tennessee Dental Association (TDA) for seven of its software solutions. This endorsement, announced Monday, is a key step in iCoreConnect's growth strategy, which hinges on gaining product endorsements from state healthcare associations.

The TDA's backing will enable its members to integrate iCoreConnect's suite of solutions, including iCoreVerify, iCoreRx, iCoreEPCS, iCorePay, iCoreAnalytics, iCoreCodeGenius, and iCoreClaims, into their practices.

This collaboration aims to enhance workflow productivity and profitability for healthcare professionals by offering a range of features such as enhanced integration with common Practice Management software, expanded functionality, comprehensive support, and flexibility through a single sign-on with modular add-ons.

Andrea Hayes, the Executive Director of the Tennessee Dental Association, expressed enthusiasm for the partnership, anticipating significant value addition to TDA members. iCoreConnect's President and CEO, Robert McDermott, echoed this sentiment, emphasizing the combined effort to drive innovation and business success in a competitive market.

The company's approach to growth involves initiating co-branded marketing campaigns with state associations to promote their endorsed products through various channels, including print, email campaigns, journals, newsletters, and more.

iCoreConnect is recognized for its cloud-based enterprise and healthcare workflow platform, with a portfolio of 16 SaaS enterprise solutions and over 100 product endorsements from state or regional healthcare associations in the United States. The company values customer feedback, which informs its market-responsive approach.

This news is based on a press release statement and includes forward-looking statements that involve known and unknown risks and uncertainties. iCoreConnect has stated that it does not intend to update any forward-looking statements beyond the date of the release, despite potential material differences that may emerge between expectations and actual outcomes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

Amid the recent endorsement from the Tennessee Dental Association, iCoreConnect Inc. (NASDAQ: ICCT) confronts a challenging financial landscape. The company's market capitalization stands at a modest $11.88 million, reflecting investor sentiment and market positioning.

With a negative price-to-earnings (P/E) ratio of -0.71 for the last twelve months as of Q4 2023, the financial metrics suggest that iCoreConnect has yet to achieve profitability, a common hurdle for growth-focused tech firms.

The company's stock price has experienced a steep decline, with a 1-year price total return of -89.3%, indicating a significant retreat from its 52-week high. This downturn is underscored by an InvestingPro Tip that notes the stock has taken a big hit over the last week.

Moreover, the company's financial health is under scrutiny, with another InvestingPro Tip revealing that short term obligations exceed liquid assets, raising concerns about liquidity and near-term financial stability.

For investors and industry observers, these financial indicators are crucial when assessing iCoreConnect's potential to leverage endorsements for sustainable growth. For those looking for a more comprehensive analysis, there are 6 additional InvestingPro Tips available, providing deeper insights into the company's financial health and market performance. Interested readers can explore these tips at https://www.investing.com/pro/ICCT and may use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.